A monoclonal antibody is a type of protein made in the laboratory that can bind to substances in the body, including cancer cells. A monoclonal antibody is made so that it binds to only one substance to treat different types of cancer. There are several types of monoclonal antibodies that are being used to treat certain types of cancer. Laboratory production of monoclonal antibodies is produced from clones of only one cell which means that every monoclonal antibody produced by the cell is the same due to which they are called as biosimilar monoclonal antibodies. Each monoclonal antibody recognizes one particular protein. They work in different ways depending on the protein they are targeting, hence different monoclonal antibodies are required to be made to target different types of cancer.
Scope of the Report:
This report focuses on the Biosimilar Monoclonal Antibodies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Biosimilar Monoclonal Antibodies is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Pfizer, Inc.
- Novartis AG
- Reliance Life Sciences
- Allergan plc
- Coherus BioSciences, Inc.
- Biocon
- Dr. Reddy's Laboratories Ltd.
- Boehringer Ingelheim GmbH
- BioXpress Therapeutics SA
- Intas Pharmaceuticals Limited
- BIOCAD
- Genor BioPharma Co. Ltd
- Celltrion, Inc.
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Rituximab
- Infliximab
- Abciximab
- Trastuzumab
- Adalimumab
- Bevacizumab
Market Segment by Applications, can be divided into
- Oncology
- Chronic and Autoimmune Diseases
- Growth Hormone Deficiency
- Infectious Diseases
- Others
There are 15 Chapters to deeply display the global Biosimilar Monoclonal Antibodies market.
Chapter 1, to describe Biosimilar Monoclonal Antibodies Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Biosimilar Monoclonal Antibodies, with sales, revenue, and price of Biosimilar Monoclonal Antibodies, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Biosimilar Monoclonal Antibodies, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Biosimilar Monoclonal Antibodies market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Biosimilar Monoclonal Antibodies sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biosimilar Monoclonal Antibodies Market 2018, Forecast to 2023
Table of Contents
1 Market Overview
1.1 Biosimilar Monoclonal Antibodies Introduction
1.2 Market Analysis by Type
1.2.1 Rituximab
1.2.2 Infliximab
1.2.3 Abciximab
1.2.4 Trastuzumab
1.2.5 Adalimumab
1.2.6 Bevacizumab
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Chronic and Autoimmune Diseases
1.3.3 Growth Hormone Deficiency
1.3.4 Infectious Diseases
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer, Inc.
2.1.1 Business Overview
2.1.1.1 Pfizer, Inc. Description
2.1.1.2 Pfizer, Inc. Headquarter, Main Business and Finance Overview
2.1.2 Pfizer, Inc. Biosimilar Monoclonal Antibodies Product Introduction
2.1.2.1 Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.1.2.2 Biosimilar Monoclonal Antibodies Product Information
2.1.3 Pfizer, Inc. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Pfizer, Inc. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Pfizer, Inc. Biosimilar Monoclonal Antibodies Market Share in 2017
2.2 Novartis AG
2.2.1 Business Overview
2.2.1.1 Novartis AG Description
2.2.1.2 Novartis AG Headquarter, Main Business and Finance Overview
2.2.2 Novartis AG Biosimilar Monoclonal Antibodies Product Introduction
2.2.2.1 Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.2.2.2 Biosimilar Monoclonal Antibodies Product Information
2.2.3 Novartis AG Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Novartis AG Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Novartis AG Biosimilar Monoclonal Antibodies Market Share in 2017
2.3 Reliance Life Sciences
2.3.1 Business Overview
2.3.1.1 Reliance Life Sciences Description
2.3.1.2 Reliance Life Sciences Headquarter, Main Business and Finance Overview
2.3.2 Reliance Life Sciences Biosimilar Monoclonal Antibodies Product Introduction
2.3.2.1 Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.3.2.2 Biosimilar Monoclonal Antibodies Product Information
2.3.3 Reliance Life Sciences Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Reliance Life Sciences Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Reliance Life Sciences Biosimilar Monoclonal Antibodies Market Share in 2017
2.4 Allergan plc
2.4.1 Business Overview
2.4.1.1 Allergan plc Description
2.4.1.2 Allergan plc Headquarter, Main Business and Finance Overview
2.4.2 Allergan plc Biosimilar Monoclonal Antibodies Product Introduction
2.4.2.1 Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.4.2.2 Biosimilar Monoclonal Antibodies Product Information
2.4.3 Allergan plc Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Allergan plc Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Allergan plc Biosimilar Monoclonal Antibodies Market Share in 2017
2.5 Coherus BioSciences, Inc.
2.5.1 Business Overview
2.5.1.1 Coherus BioSciences, Inc. Description
2.5.1.2 Coherus BioSciences, Inc. Headquarter, Main Business and Finance Overview
2.5.2 Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Product Introduction
2.5.2.1 Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.5.2.2 Biosimilar Monoclonal Antibodies Product Information
2.5.3 Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Market Share in 2017
2.6 Biocon
2.6.1 Business Overview
2.6.1.1 Biocon Description
2.6.1.2 Biocon Headquarter, Main Business and Finance Overview
2.6.2 Biocon Biosimilar Monoclonal Antibodies Product Introduction
2.6.2.1 Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.6.2.2 Biosimilar Monoclonal Antibodies Product Information
2.6.3 Biocon Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Biocon Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Biocon Biosimilar Monoclonal Antibodies Market Share in 2017
2.7 Dr. Reddy's Laboratories Ltd.
2.7.1 Business Overview
2.7.1.1 Dr. Reddy's Laboratories Ltd. Description
2.7.1.2 Dr. Reddy's Laboratories Ltd. Headquarter, Main Business and Finance Overview
2.7.2 Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Product Introduction
2.7.2.1 Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.7.2.2 Biosimilar Monoclonal Antibodies Product Information
2.7.3 Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Market Share in 2017
2.8 Boehringer Ingelheim GmbH
2.8.1 Business Overview
2.8.1.1 Boehringer Ingelheim GmbH Description
2.8.1.2 Boehringer Ingelheim GmbH Headquarter, Main Business and Finance Overview
2.8.2 Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Product Introduction
2.8.2.1 Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.8.2.2 Biosimilar Monoclonal Antibodies Product Information
2.8.3 Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Market Share in 2017
2.9 BioXpress Therapeutics SA
2.9.1 Business Overview
2.9.1.1 BioXpress Therapeutics SA Description
2.9.1.2 BioXpress Therapeutics SA Headquarter, Main Business and Finance Overview
2.9.2 BioXpress Therapeutics SA Biosimilar Monoclonal Antibodies Product Introduction
2.9.2.1 Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.9.2.2 Biosimilar Monoclonal Antibodies Product Information
2.9.3 BioXpress Therapeutics SA Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 BioXpress Therapeutics SA Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global BioXpress Therapeutics SA Biosimilar Monoclonal Antibodies Market Share in 2017
2.10 Intas Pharmaceuticals Limited
2.10.1 Business Overview
2.10.1.1 Intas Pharmaceuticals Limited Description
2.10.1.2 Intas Pharmaceuticals Limited Headquarter, Main Business and Finance Overview
2.10.2 Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibodies Product Introduction
2.10.2.1 Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
2.10.2.2 Biosimilar Monoclonal Antibodies Product Information
2.10.3 Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibodies Market Share in 2017
2.11 BIOCAD
2.11.1 Business Overview
2.11.2 BIOCAD Biosimilar Monoclonal Antibodies Product Introduction
2.11.3 BIOCAD Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Genor BioPharma Co. Ltd
2.12.1 Business Overview
2.12.2 Genor BioPharma Co. Ltd Biosimilar Monoclonal Antibodies Product Introduction
2.12.3 Genor BioPharma Co. Ltd Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Celltrion, Inc.
2.13.1 Business Overview
2.13.2 Celltrion, Inc. Biosimilar Monoclonal Antibodies Product Introduction
2.13.3 Celltrion, Inc. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biosimilar Monoclonal Antibodies Market Competition, by Manufacturer
3.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Biosimilar Monoclonal Antibodies Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Biosimilar Monoclonal Antibodies Manufacturer Market Share in 2017
3.4.2 Top 5 Biosimilar Monoclonal Antibodies Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Biosimilar Monoclonal Antibodies Market Analysis by Regions
4.1 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Regions
4.1.1 Global Biosimilar Monoclonal Antibodies Sales by Regions (2013-2018)
4.1.2 Global Biosimilar Monoclonal Antibodies Revenue by Regions (2013-2018)
4.2 North America Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate (2013-2018)
5 North America Biosimilar Monoclonal Antibodies by Countries, Type, Application and Manufacturers
5.1 North America Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries
5.1.1 North America Biosimilar Monoclonal Antibodies Sales by Countries (2013-2018)
5.1.2 North America Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018)
5.1.3 United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
5.1.4 Canada Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
5.1.5 Mexico Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
5.2 North America Biosimilar Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Biosimilar Monoclonal Antibodies Sales by Manufacturers (2016-2017)
5.2.2 North America Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
5.3 North America Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Biosimilar Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
5.3.2 North America Biosimilar Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
5.4 North America Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Biosimilar Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
5.4.2 North America Biosimilar Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)
6 Europe Biosimilar Monoclonal Antibodies by Countries, Type, Application and Manufacturers
6.1 Europe Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries
6.1.1 Europe Biosimilar Monoclonal Antibodies Sales by Countries (2013-2018)
6.1.2 Europe Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018)
6.1.3 Germany Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.1.4 UK Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.1.5 France Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.1.6 Russia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.1.7 Italy Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.2 Europe Biosimilar Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Biosimilar Monoclonal Antibodies Sales by Manufacturers (2016-2017)
6.2.2 Europe Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
6.3 Europe Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Biosimilar Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Biosimilar Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Biosimilar Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Biosimilar Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Biosimilar Monoclonal Antibodies by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018)
7.1.3 China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.1.4 Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.1.5 Korea Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.1.6 India Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Biosimilar Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Biosimilar Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Biosimilar Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Biosimilar Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Biosimilar Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)
8 South America Biosimilar Monoclonal Antibodies by Countries, Type, Application and Manufacturers
8.1 South America Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries
8.1.1 South America Biosimilar Monoclonal Antibodies Sales by Countries (2013-2018)
8.1.2 South America Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018)
8.1.3 Brazil Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
8.1.4 Argentina Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
8.1.5 Colombia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
8.2 South America Biosimilar Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Biosimilar Monoclonal Antibodies Sales by Manufacturers (2016-2017)
8.2.2 South America Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
8.3 South America Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Biosimilar Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
8.3.2 South America Biosimilar Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
8.4 South America Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Biosimilar Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
8.4.2 South America Biosimilar Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Biosimilar Monoclonal Antibodies by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.1.4 UAE Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.1.5 Egypt Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.1.7 South Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Biosimilar Monoclonal Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue and Revenue Share by Application (2013-2018)
10 Global Biosimilar Monoclonal Antibodies Market Segment by Type
10.1 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2013-2018)
10.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2013-2018)
10.2 Rituximab Sales Growth and Price
10.2.1 Global Rituximab Sales Growth (2013-2018)
10.2.2 Global Rituximab Price (2013-2018)
10.3 Infliximab Sales Growth and Price
10.3.1 Global Infliximab Sales Growth (2013-2018)
10.3.2 Global Infliximab Price (2013-2018)
10.4 Abciximab Sales Growth and Price
10.4.1 Global Abciximab Sales Growth (2013-2018)
10.4.2 Global Abciximab Price (2013-2018)
10.5 Trastuzumab Sales Growth and Price
10.5.1 Global Trastuzumab Sales Growth (2013-2018)
10.5.2 Global Trastuzumab Price (2013-2018)
10.6 Adalimumab Sales Growth and Price
10.6.1 Global Adalimumab Sales Growth (2013-2018)
10.6.2 Global Adalimumab Price (2013-2018)
10.7 Bevacizumab Sales Growth and Price
10.7.1 Global Bevacizumab Sales Growth (2013-2018)
10.7.2 Global Bevacizumab Price (2013-2018)
11 Global Biosimilar Monoclonal Antibodies Market Segment by Application
11.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Chronic and Autoimmune Diseases Sales Growth (2013-2018)
11.4 Growth Hormone Deficiency Sales Growth (2013-2018)
11.5 Infectious Diseases Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)
12.1 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate (2018-2023)
12.2 Biosimilar Monoclonal Antibodies Market Forecast by Regions (2018-2023)
12.2.1 North America Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)
12.2.2 Europe Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)
12.2.3 Asia-Pacific Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)
12.2.4 South America Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)
12.2.5 Middle East and Africa Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)
12.3 Biosimilar Monoclonal Antibodies Market Forecast by Type (2018-2023)
12.3.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2018-2023)
12.3.2 Global Biosimilar Monoclonal Antibodies Market Share Forecast by Type (2018-2023)
12.4 Biosimilar Monoclonal Antibodies Market Forecast by Application (2018-2023)
12.4.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2018-2023)
12.4.2 Global Biosimilar Monoclonal Antibodies Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Biosimilar Monoclonal Antibodies Picture
Table Product Specifications of Biosimilar Monoclonal Antibodies
Figure Global Biosimilar Monoclonal Antibodies CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Biosimilar Monoclonal Antibodies CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Biosimilar Monoclonal Antibodies by Types in 2017
Figure Rituximab Picture
Table Major Manufacturers of Rituximab
Figure Infliximab Picture
Table Major Manufacturers of Infliximab
Figure Abciximab Picture
Table Major Manufacturers of Abciximab
Figure Trastuzumab Picture
Table Major Manufacturers of Trastuzumab
Figure Adalimumab Picture
Table Major Manufacturers of Adalimumab
Figure Bevacizumab Picture
Table Major Manufacturers of Bevacizumab
Figure Biosimilar Monoclonal Antibodies Sales Market Share by Applications in 2017
Figure Oncology Picture
Figure Chronic and Autoimmune Diseases Picture
Figure Growth Hormone Deficiency Picture
Figure Infectious Diseases Picture
Figure Others Picture
Figure United States Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure France Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure UK Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure China Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure India Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Biosimilar Monoclonal Antibodies Revenue (Value) and Growth Rate (2013-2023)
Table Pfizer, Inc. Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer, Inc. Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Pfizer, Inc. Biosimilar Monoclonal Antibodies Product
Table Pfizer, Inc. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer, Inc. Biosimilar Monoclonal Antibodies Sales Market Share in 2017
Figure Global Pfizer, Inc. Biosimilar Monoclonal Antibodies Revenue Market Share in 2017
Table Novartis AG Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis AG Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Novartis AG Biosimilar Monoclonal Antibodies Product
Table Novartis AG Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis AG Biosimilar Monoclonal Antibodies Sales Market Share in 2017
Figure Global Novartis AG Biosimilar Monoclonal Antibodies Revenue Market Share in 2017
Table Reliance Life Sciences Headquarter, Established, Main Business and Finance Overview (2017)
Table Reliance Life Sciences Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Reliance Life Sciences Biosimilar Monoclonal Antibodies Product
Table Reliance Life Sciences Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Reliance Life Sciences Biosimilar Monoclonal Antibodies Sales Market Share in 2017
Figure Global Reliance Life Sciences Biosimilar Monoclonal Antibodies Revenue Market Share in 2017
Table Allergan plc Headquarter, Established, Main Business and Finance Overview (2017)
Table Allergan plc Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Allergan plc Biosimilar Monoclonal Antibodies Product
Table Allergan plc Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Allergan plc Biosimilar Monoclonal Antibodies Sales Market Share in 2017
Figure Global Allergan plc Biosimilar Monoclonal Antibodies Revenue Market Share in 2017
Table Coherus BioSciences, Inc. Headquarter, Established, Main Business and Finance Overview (2017)
Table Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Product
Table Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Sales Market Share in 2017
Figure Global Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Revenue Market Share in 2017
Table Biocon Headquarter, Established, Main Business and Finance Overview (2017)
Table Biocon Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Biocon Biosimilar Monoclonal Antibodies Product
Table Biocon Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Biocon Biosimilar Monoclonal Antibodies Sales Market Share in 2017
Figure Global Biocon Biosimilar Monoclonal Antibodies Revenue Market Share in 2017
Table Dr. Reddy's Laboratories Ltd. Headquarter, Established, Main Business and Finance Overview (2017)
Table Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Product
Table Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Sales Market Share in 2017
Figure Global Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Revenue Market Share in 2017
Table Boehringer Ingelheim GmbH Headquarter, Established, Main Business and Finance Overview (2017)
Table Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Product
Table Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Sales Market Share in 2017
Figure Global Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Revenue Market Share in 2017
Table BioXpress Therapeutics SA Headquarter, Established, Main Business and Finance Overview (2017)
Table BioXpress Therapeutics SA Biosimilar Monoclonal Antibodies Production Bases, Sales Regions and Major Competitors
Table BioXpress Therapeutics SA Biosimilar Monoclonal Antibodies Product
Table BioXpress Therapeu
Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 147
According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period.
The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
Global Biosimilar Drug Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 147
According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period.
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
Global Biosimilars Market Research Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 2680 Onwards Pages: 167
A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
Global Biosimilars Professional Survey Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 3280 Onwards Pages: 133
A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 07-Dec-2023 Price: US 3380 Onwards Pages: 106
Market Overview of Global Biosimilars market:
According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years.
A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
Published: 24-Nov-2023 Price: US 3280 Onwards Pages: 134
Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
Published: 24-Nov-2023 Price: US 2680 Onwards Pages: 160
Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 16-Nov-2023 Price: US 3380 Onwards Pages: 103
Market Overview of Global Biosimilar Monoclonal Antibodies market:
According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
